Fumitaka Tanaka
Overview
Explore the profile of Fumitaka Tanaka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Konta T, Asahi K, Tamura K, Tanaka F, Fukui A, Nakamura Y, et al.
Clin Exp Nephrol
. 2024 Dec;
PMID: 39676148
Background: The objective of this analysis was to estimate the clinical and economic impact of undertaking urine albumin-to-creatinine ratio (UACR) testing alongside regular estimated glomerular filtration rate testing for chronic...
2.
Asahi K, Konta T, Tamura K, Tanaka F, Fukui A, Nakamura Y, et al.
J Diabetes Investig
. 2024 Nov;
16(1):108-119.
PMID: 39576736
Aims/introduction: This analysis seeks to evaluate the cost-effectiveness of urine albumin-to-creatinine ratio testing compared with urine protein-creatinine ratio testing and no urine testing for the identification of kidney damage in...
3.
Takahashi N, Tsubota-Utsugi M, Takahashi S, Yonekura Y, Ohsawa M, Kuribayashi T, et al.
Inquiry
. 2024 Aug;
61:469580241273103.
PMID: 39183635
Whether the association between metabolic syndrome (MetS) and functional disability differs depending on sex or age remains unknown. To determine the association between MetS and functional disability in older people...
4.
Tsubota-Utsugi M, Tanno K, Takahashi N, Onoda T, Yonekura Y, Ohsawa M, et al.
Geriatr Gerontol Int
. 2023 Sep;
23(11):809-816.
PMID: 37770036
Aim: To fill the knowledge gap regarding weight change and the onset of disability in community-dwelling Japanese older adults, we investigated the potential effects of rapid weight change on disability...
5.
Kotozaki Y, Satoh M, Nasu T, Tanno K, Tanaka F, Sasaki M
Biomedicines
. 2023 Mar;
11(3).
PMID: 36979733
Xanthine oxidoreductase (XOR) and its products contribute to the development of chronic inflammation and oxidative stress. Excessive XOR activity is believed to promote inflammatory responses and atherosclerotic plaque formation, which...
6.
Mikami T, Tanno K, Sasaki R, Takanashi N, Kotozaki Y, Asahi K, et al.
Hypertens Res
. 2023 Feb;
46(5):1247-1256.
PMID: 36806793
People who experience natural disasters have a high risk of developing cardiovascular diseases. We investigated the association between the extent of house collapse and urine sodium-to-potassium (UNa/K) ratio of 2011...
7.
Kikuchi Y, Odashima Y, Yoshikawa K, Oda T, Tanaka F, Oikawa H, et al.
BMC Nephrol
. 2022 Nov;
23(1):380.
PMID: 36443705
No abstract available.
8.
Taguchi S, Nasu T, Satoh M, Kotozaki Y, Tanno K, Tanaka F, et al.
Kidney Blood Press Res
. 2022 Nov;
47(12):722-728.
PMID: 36318900
Introduction: Xanthine oxidoreductase (XOR) has been identified as a critical source of reactive oxygen species in various pathophysiological conditions, including hypertension, endothelial dysfunction, and atherosclerosis. This study investigated the association...
9.
Kikuchi Y, Odashima Y, Yoshikawa K, Oda T, Tanaka F, Oikawa H, et al.
BMC Nephrol
. 2022 Oct;
23(1):348.
PMID: 36309669
Background: Vascular endothelial growth factor inhibitors (VEGFIs) are used to treat malignant neoplasms and ocular diseases by inhibiting angiogenesis. Systemic use of VEGFIs has various side effects, including hypertension, proteinuria,...
10.
Tanno K, Yonekura Y, Okuda N, Kuribayashi T, Yabe E, Tsubota-Utsugi M, et al.
Nutrients
. 2021 Nov;
13(11).
PMID: 34836038
We aimed to evaluate the association between the milk consumption and incident stroke in a Japanese population, where milk consumption is lower than that of Western countries. In total, 14,121...